NCT01024309

Brief Summary

The purpose is to determine if differences exist in the attainment of functional milestones that reflect activities of daily living between mini-posterior and direct anterior approach total hip arthroplasty (THA). The investigators also hope to determine if the general health outcome after direct anterior total hip arthroplasty was better than that after mini-posterior-incision total hip arthroplasty as measured with Short Form-12 (SF-12) scores, and to evaluate variation of surgical factors of the two procedures on the basis of the operative time, component positioning, and occurrence of early complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2009

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

November 30, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 2, 2009

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

October 30, 2014

Completed
Last Updated

October 30, 2014

Status Verified

October 1, 2014

Enrollment Period

3.8 years

First QC Date

November 30, 2009

Results QC Date

December 31, 2013

Last Update Submit

October 28, 2014

Conditions

Keywords

total hip arthroplasty

Outcome Measures

Primary Outcomes (1)

  • Number of Days for Discontinue Assistive Devices

    The primary early functional endpoint is the difference between groups in the postoperative days that patients require any assistive devices for ambulation. Lower number of days indicate better outcomes.

    6 week

Secondary Outcomes (8)

  • Harris Hip Score

    3 week

  • Western Ontario and McMaster Universities Arthritis Index (WOMAC)

    3 week

  • Abduction Angle

    6 wk

  • Anteversion Angle

    6 week

  • Harris Hip Score

    6 week

  • +3 more secondary outcomes

Study Arms (2)

Mini-Posterior Approach

ACTIVE COMPARATOR

Mini-Posterior surgical approach for total hip arthroplasty

Procedure: Mini-Posterior surgical approach for total hip arthroplasty

Direct Anterior Approach

EXPERIMENTAL

Direct Anterior surgical approach for total hip arthroplasty

Procedure: Direct Anterior surgical approach for total hip arthroplasty

Interventions

Mini-Posterior surgical approach for total hip arthroplasty

Mini-Posterior Approach

Direct Anterior surgical approach for total hip arthroplasty

Direct Anterior Approach

Eligibility Criteria

Age25 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The subject is willing and able to understand, sign and date the study specific Patient Informed Consent and Health Insurance Portability and Accountability Act (HIPPA) authorization to volunteer participation in the study.
  • The subject is between 25 and 80 years of age at the time of surgery.
  • The subject has elected to undergo primary total hip arthroplasty for osteoarthritis.
  • The subject is psychosocially, mentally and physically able to comply with the requirements of the study including post-operative clinical, radiographic evaluations and completion of patient questionnaires.
  • The subject is skeletally mature.

You may not qualify if:

  • The subject has a BMI greater than 35.
  • The subject has had a previous total hip arthroplasty.
  • The subject has inflammatory arthritis.
  • The subject has any type of infection.
  • The subject has developmental dysplasia of the hip.
  • The subject has a known metal allergy.
  • The subject has an extreme offset of greater than 50 mm.
  • The subject has an acetabular deformity requiring advanced reconstructive techniques.
  • The subject has Charcot's disease.
  • The subject has Paget's disease
  • Dependence on narcotics for 6 months (or longer)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OrthoCarolina, P.A.

Charlotte, North Carolina, 28207, United States

Location

MeSH Terms

Conditions

Osteoarthritis

Interventions

Arthroplasty, Replacement, Hip

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Results Point of Contact

Title
Dr. Susan Odum
Organization
OrthoCarolina Research Institute

Study Officials

  • John Bohannon Mason, MD

    OrthoCarolina, P.A.

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2009

First Posted

December 2, 2009

Study Start

November 1, 2009

Primary Completion

September 1, 2013

Study Completion

September 1, 2013

Last Updated

October 30, 2014

Results First Posted

October 30, 2014

Record last verified: 2014-10

Locations